TXNIP and metabolic dysfunction-associated steatohepatitis: Statins prevented the progression of MCDD-induced NASH in a C57BL/6J mice model by increasing mitochondrial and peroxisomal FAO [45], meanwhile TXNIP/VDUP1 was also effective against steatohepatitis via FAO [46].